Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Journal of Cancer Survivorship
Published in: Journal of Cancer Survivorship 1/2021

Open Access 01-02-2021 | Prostate Cancer

Cumulative financial stress as a potential risk factor for cancer-related fatigue among prostate cancer survivors

Authors: Liya Lu, Anna Gavin, Frances J. Drummond, Linda Sharp

Published in: Journal of Cancer Survivorship | Issue 1/2021

Login to get access

Abstract

Introduction

Cancer-related fatigue (CRF) is the most commonly reported treatment-related side effect of prostate cancer (PCa). Recognition of financial hardship among cancer survivors is growing. We investigated, for the first time, associations between levels of financial stress and CRF among PCa survivors.

Methods

We used data from PCa survivors who had been identified through two population-based cancer registries covering the Republic of Ireland and Northern Ireland and had completed a postal questionnaire. CRF was measured by the fatigue subscale of the EORTC QLQ-C30. Financial stress was assessed as household ability to make ends meet (i) pre-diagnosis and (ii) at questionnaire completion (post-diagnosis). Multivariable logistic regression was used to relate financial stress to clinically important CRF (fatigue subscale score ≥ 39 of a possible 100).

Results

Two thousand four hundred fifty-eight PCa survivors were included. Of these, 268 (10.9%) reported pre-diagnosis financial stress only, 317 (12.9%) post-diagnosis stress only and 270 (11.0%) both pre- and post-diagnosis stress (cumulative stress); 470 (19.1%) reported clinically important CRF. After controlling for confounders, survivors with cumulative financial stress exposure were significantly more likely to have CRF (OR = 4.58, 95% CI 3.30–6.35, p < 0.001), compared with those without financial stress. There was a suggestion of a dose-response relationship (OR = 1.83, 95% CI 1.27–2.65, p = 0.001 for pre-diagnosis financial stress only; and OR = 4.11, 95% CI 3.01–5.61, p < 0.001 for post-diagnosis financial stress only).

Conclusions

Financial stress may be an independent risk factor for CRF.

Implications for Cancer Survivors

There may be benefits in targeting interventions for reducing CRF towards survivors with financial stress, or developing strategies to reduce financial stress.
Appendix
Available only for authorised users
Literature
1.
Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424.CrossRefPubMed
2.
Allemani C, Matsuda T, Di Carlo V, Harewood R, Matz M, Nikšić M, et al. Global surveillance of trends in cancer survival 2000–14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries. Lancet. 2018;391(10125):1023–75.PubMedPubMedCentral
3.
DeSantis CE, Lin CC, Mariotto AB, Siegel RL, Stein KD, Kramer JL, et al. Cancer treatment and survivorship statistics, 2014. CA Cancer J Clin. 2014;64(4):252–71.PubMed
4.
Maddams J, Brewster D, Gavin A, Steward J, Elliott J, Utley M, et al. Cancer prevalence in the United Kingdom: estimates for 2008. Br J Cancer. 2009;101(3):541–7.PubMedPubMedCentral
5.
6.
Maddams J, Utley M, Møller H. Projections of cancer prevalence in the United Kingdom, 2010–2040. Br J Cancer. 2012;107(7):1195–202.PubMedPubMedCentral
7.
Mock V. Fatigue management: evidence and guidelines for practice. Cancer. 2001;92(6 Suppl):1699–7077.PubMed
8.
9.
10.
Baguley BJ, Bolam KA, Wright ORL, Skinner TL. The effect of nutrition therapy and exercise on cancer-related fatigue and quality of life in men with prostate cancer: a systematic review. Nutrients. 2017;9(9):1003.
11.
12.
Wilding S, Downing A, Wright L, Selby P, Watson E, Wagland R, et al. Cancer-related symptoms, mental well-being, and psychological distress in men diagnosed with prostate cancer treated with androgen deprivation therapy. Qual Life Res. 28(10):2741–51.
13.
Curt GA, Breitbart W, Cella D, Groopman JE, Horning SJ, Itri LM, et al. Impact of cancer-related fatigue on the lives of patients: new findings from the fatigue coalition. Oncologist. 2000;5(5):353–60.PubMed
14.
Bower JE, Ganz PA, Desmond KA, Bernaards C, Rowland JH, Meyerowitz BE, et al. Fatigue in long-term breast carcinoma survivors: a longitudinal investigation. Cancer. 2006;106(4):751–8.PubMed
15.
Bower JE, Ganz PA, Desmond KA, Rowland JH, Meyerowitz BE, Belin TR. Fatigue in breast cancer survivors: occurrence, correlates, and impact on quality of life. J Clin Oncol. 2000;18(4):743–53.PubMed
16.
Gerber LH, Stout N, McGarvey C, Soballe P, Shieh CY, Diao G, et al. Factors predicting clinically significant fatigue in women following treatment for primary breast cancer. Support Care Cancer. 2011;19(10):1581–91.PubMed
17.
Goldstein D, Bennett BK, Webber K, Boyle F, de Souza PL, Wilcken NR, et al. Cancer-related fatigue in women with breast cancer: outcomes of a 5-year prospective cohort study. J Clin Oncol. 2012;30(15):1805–12.PubMed
18.
Pertl MM, Hevey D, Collier S, Lambe K, O'Dwyer AM. Predictors of fatigue in cancer patients before and after chemotherapy. J Health Psychol. 2014;19(6):699–710.PubMed
19.
Altice CK, Banegas MP, Tucker-Seeley RD, Yabroff KR. Financial hardships experienced by cancer survivors: a systematic review. J Natl Cancer Inst. 2017;109(2):djw205.
20.
Azzani M, Roslani AC, Su TT. The perceived cancer-related financial hardship among patients and their families: a systematic review. Support Care Cancer. 2015;23(3):889–98.PubMed
21.
Bradley CJ. Financial hardship: a consequence of survivorship? J Clin Oncol. 2012;30(14):1579–80.PubMed
22.
Gordon LG, Merollini KMD, Lowe A, Chan RJ. A systematic review of financial toxicity among cancer survivors: we can’t pay the co-pay. Patient. 2017;10(3):295–309.PubMed
23.
Lu L, O'Sullivan E, Sharp L. Cancer-related financial hardship among head and neck cancer survivors: risk factors and associations with health-related quality of life. Psychooncology. 2019;28(4):863–71.PubMed
24.
Benoit FR. Cumulative financial stress and strain in palliative radiation outpatients: the role of age and disability. Acta Oncol. 2005;44(4):369–81.
25.
Banegas MP, Guy GP Jr, de Moor JS, Ekwueme DU, Virgo KS, Kent EE, et al. For working-age cancer survivors, medical debt and bankruptcy create financial hardships. Health Aff (Millwood). 2016;35(1):54–61.
26.
Zafar SY, McNeil RB, Thomas CM, Lathan CS, Ayanian JZ, Provenzale D. Population-based assessment of cancer survivors' financial burden and quality of life: a prospective cohort study. J Oncol Pract. 2014;11(2):145–50.PubMedPubMedCentral
27.
Shankaran V, Jolly S, Blough D, Ramsey SD. Risk factors for financial hardship in patients receiving adjuvant chemotherapy for colon cancer: a population-based exploratory analysis. J Clin Oncol. 2012;30(14):1608–14.PubMed
28.
Sharp L, Carsin AE, Timmons A. Associations between cancer-related financial stress and strain and psychological well-being among individuals living with cancer. Psychooncology. 2013;22(4):745–55.PubMed
29.
Ell K, Xie B, Wells A, Nedjat-Haiem F, Lee PJ, Vourlekis B. Economic stress among low-income women with cancer: effects on quality of life. Cancer. 2008;112(3):616–25.PubMed
30.
Fenn KM, Evans SB, McCorkle R, DiGiovanna MP, Pusztai L, Sanft T, et al. Impact of financial burden of cancer on survivors' quality of life. J Oncol Pract. 2014;10(5):332–8.PubMed
31.
Shao Z, Zhu T, Zhang P, Wen Q, Li D, Wang S. Association of financial status and the quality of life in Chinese women with recurrent ovarian cancer. Health Qual Life Outcomes. 2017;15(1):144.PubMedPubMedCentral
32.
Chan RJ, Gordon L, Zafar SY, Miaskowski C. Financial toxicity and symptom burden: what is the big deal? Support Care Cancer. 2018;26(5):1357–9.PubMed
33.
Drummond FJ, Kinnear H, Donnelly C, O'Leary E, O'Brien K, Burns RM, et al. Establishing a population-based patient-reported outcomes study (PROMs) using national cancer registries across two jurisdictions: the Prostate Cancer Treatment, your experience (PiCTure) study. BMJ Open. 2015;5(4):e006851.PubMedPubMedCentral
34.
Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst. 1993;85(5):365–76.PubMed
35.
Groenvold M, Klee MC, Sprangers MAG, Aaronson NK. Validation of the EORTC QLQ-C30 quality of life questionnaire through combined qualitative and quantitative assessment of patient-observer agreement. J Clin Epidemiol. 1997;50(4):441–50.PubMed
36.
Giesinger JM, Kuijpers W, Young T, Tomaszewski KA, Friend E, Zabernigg A, et al. Thresholds for clinical importance for four key domains of the EORTC QLQ-C30: physical functioning, emotional functioning, fatigue and pain. Health Qual Life Outcomes. 2016;14:87.PubMedPubMedCentral
37.
Sharp L, O’Leary E, O’Ceilleachair A, Skally M, Hanly P. Financial impact of colorectal cancer and its consequences: associations between cancer-related financial stress and strain and health-related quality of life. Dis Colon Rectum. 2018;61(1):27–35.PubMed
38.
Hosmer DW, Lemeshow S, Klar J. Goodness-of-fit testing for the logistic-regression model when the estimated probabilities are small. Biom J. 1988;30(8):911–24.
39.
Chan RJ, Gordon LG, Tan CJ, Chan A, Bradford NK, Yates P, et al. Relationships between financial toxicity and symptom burden in cancer survivors: a systematic review. J Pain Symptom Manag. 2019;57(3):646–60.
40.
Housser E, Mathews M, Lemessurier J, Young S, Hawboldt J, West R. Responses by breast and prostate cancer patients to out-of-pocket costs in Newfoundland and Labrador. Curr Oncol. 2013;20(3):158–65.PubMedPubMedCentral
41.
Sharp L, Timmons A. Pre-diagnosis employment status and financial circumstances predict cancer-related financial stress and strain among breast and prostate cancer survivors. Support Care Cancer. 2016;24(2):699–709.PubMed
42.
43.
Delgado-Guay M, Ferrer J, Rieber AG, Rhondali W, Tayjasanant S, Ochoa J, et al. Financial distress and its associations with physical and emotional symptoms and quality of life among advanced cancer patients. Oncologist. 2015;20(9):1092–8.PubMedPubMedCentral
44.
Lathan CS, Cronin A, Tucker-Seeley R, Zafar SY, Ayanian JZ, Schrag D. Association of financial strain with symptom burden and quality of life for patients with lung or colorectal cancer. J Clin Oncol. 2016;34(15):1732–40.PubMedPubMedCentral
45.
Barbaret C, Brosse C, Rhondali W, Ruer M, Monsarrat L, Michaud P, et al. Financial distress in patients with advanced cancer. PLOS ONE 2017;12(5):e0176470.
46.
Charalambous A, Kouta C. Cancer related fatigue and quality of life in patients with advanced prostate cancer undergoing chemotherapy. Biomed Res Int. 2016;2016:3989286.PubMedPubMedCentral
47.
Luo HC, Lei Y, Cheng HH, Fu ZC, Liao SG, Feng J, et al. Long-term cancer-related fatigue outcomes in patients with locally advanced prostate cancer after intensity-modulated radiotherapy combined with hormonal therapy. Medicine (Baltimore). 2016;95(25):e3948.
48.
Mehnert A. Employment and work-related issues in cancer survivors. Crit Rev Oncol Hematol. 2011;77(2):109–30.PubMed
49.
Islam T, Dahlui M, Majid HA, Nahar AM, Mohd Taib NA, Su TT, et al. Factors associated with return to work of breast cancer survivors: a systematic review. BMC Public Health. 2014;14 Suppl 3:S8.PubMed
50.
Wolvers MDJ, Leensen MCJ, Groeneveld IF, Frings-Dresen MHW, De Boer A. Predictors for earlier return to work of cancer patients. J Cancer Surviv. 2018;12(2):169–77.PubMed
51.
Bennett D, Kearney T, Donnelly DW, Downing A, Wright P, Wilding S, et al. Factors influencing job loss and early retirement in working men with prostate cancerfindings from the population-based Life After Prostate Cancer Diagnosis (LAPCD) study. J Cancer Surviv. 2018;12(5):669–78.PubMedPubMedCentral
52.
Torp S, Paraponaris A, Van Hoof E, Lindbohm ML, Tamminga SJ, Alleaume C, et al. Work-related outcomes in self-employed cancer survivors: a European multi-country study. J Occup Rehabil. 2019;29(2):361–74.PubMed
53.
54.
Mustian KM, Alfano CM, Heckler C, Kleckner AS, Kleckner IR, Leach CR, et al. Comparison of pharmaceutical, psychological, and exercise treatments for cancer-related fatigue: a meta-analysis. JAMA Oncol. 2017;3(7):961–8.PubMedPubMedCentral
55.
56.
Mayer A, Foster M. Understanding recession and self-rated health with the partial proportional odds model: an analysis of 26 countries. PLoS One. 2015;10(10):e0140724.PubMedPubMedCentral
57.
Marshall GL, Tucker-Seeley R. The association between hardship and self-rated health: does the choice of indicator matter? Ann Epidemiol. 2018;28(7):462–7.PubMedPubMedCentral
58.
Engberg I, Segerstedt J, Waller G, Wennberg P, Eliasson M. Fatigue in the general population- associations to age, sex, socioeconomic status, physical activity, sitting time and self-rated health: the northern Sweden MONICA study 2014. BMC Public Health. 2017;17(1):654.PubMedPubMedCentral
59.
Kohler N, Gansera L, Holze S, Friedrich M, Rebmann U, Stolzenburg JU, et al. Cancer-related fatigue in patients before and after radical prostatectomy. Results of a prospective multi-centre study. Support Care Cancer. 2014;22(11):2883–9.PubMed
60.
O'Ceilleachair A, Costello L, Finn C, Timmons A, Fitzpatrick P, Kapur K, et al. Inter-relationships between the economic and emotional consequences of colorectal cancer for patients and their families: a qualitative study. BMC Gastroenterol. 2012;12:62.
61.
Meeker CR, Geynisman DM, Egleston BL, Hall MJ, Mechanic KY, Bilusic M, et al. Relationships among financial distress, emotional distress, and overall distress in insured patients with cancer. J Oncol Pract. 2016;12(7):e755–64.PubMedPubMedCentral
62.
Saligan LN, Kim HS. A systematic review of the association between immunogenomic markers and cancer-related fatigue. Brain Behav Immun. 2012;26(6):830–48.PubMedPubMedCentral
63.
64.
Thong MSY, Mols F, van de Poll-Franse LV, Sprangers MAG, van der Rijt CCD, Barsevick AM, et al. Identifying the subtypes of cancer-related fatigue: results from the population-based PROFILES registry. J Cancer Surviv. 2018;12(1):38–46.PubMed
65.
Colloca G, Venturino A, Governato I, Checcaglini F. Incidence and correlates of fatigue in metastatic castration-resistant prostate cancer: a systematic review. Clin Genitourin Cancer. 2016;14(1):5–11.PubMed
66.
Irvine D, Vincent L, Graydon JE, Bubela N, Thompson L. The prevalence and correlates of fatigue in patients receiving treatment with chemotherapy and radiotherapy. A comparison with the fatigue experienced by healthy individuals. Cancer Nurs. 1994;17(5):367–78.PubMed
67.
Tabrizi FM, Alizadeh S. Cancer related fatigue in breast cancer survivors: in correlation to demographic factors. Maedica (Buchar). 2017;12(2):106–11.
68.
Deimling GT, Bowman KF, Wagner LJ. The effects of cancer-related pain and fatigue on functioning of older adult, Long-Term Cancer Survivors. Cancer Nurs. 2007;30(6):421–33.PubMed
69.
Friedrich M, Nowe E, Hofmeister D, Kuhnt S, Leuteritz K, Sender A, et al. Psychometric properties of the fatigue questionnaire EORTC QLQ-FA12 and proposal of a cut-off value for young adults with cancer. Health Qual Life Outcomes. 2018;16:125.PubMedPubMedCentral
70.
Mendoza T, Wang XS, Cleeland CS, et al. The rapid assessment of fatigue severity in cancer patients: use of the Brief Fatigue Inventory. Cancer. 1999;85:1186–96.PubMed
71.
Khera N, Holland JC, Griffin JM. Setting the stage for universal financial distress screening in routine cancer care. Cancer. 2017;123(21):4092–6.PubMed
72.
de Souza JA, Yap BJ, Wroblewski K, Blinder V, Araujo FS, Hlubocky FJ, et al. Measuring financial toxicity as a clinically relevant patient-reported outcome: the validation of the COmprehensive Score for financial Toxicity (COST). Cancer. 2017;123(3):476–84.PubMed
73.
74.
Moffatt S, Noble E, Exley C. “Done more for me in a fortnight than anybody done in all me life.” How welfare rights advice can help people with cancer. BMC Health Serv Res. 2010;10:259.PubMedPubMedCentral
75.
76.
77.
Metadata
Title
Cumulative financial stress as a potential risk factor for cancer-related fatigue among prostate cancer survivors
Authors
Liya Lu
Anna Gavin
Frances J. Drummond
Linda Sharp
Publication date
01-02-2021
Publisher
Springer US
Published in
Journal of Cancer Survivorship / Issue 1/2021
Print ISSN: 1932-2259
Electronic ISSN: 1932-2267
DOI
https://doi.org/10.1007/s11764-020-00906-7

Other articles of this Issue 1/2021

Journal of Cancer Survivorship 1/2021 Go to the issue

Correction

Correction to: Supporting employers to enhance the return to work of cancer survivors: development of a web-based intervention (MiLES intervention)

OriginalPaper

Hispanic ethnicity as a moderator of the effects of aerobic and resistance exercise on physical fitness and quality-of-life in breast cancer survivors

Review

Identifying the supportive care needs of men and women affected by chemotherapy-induced alopecia? A systematic review

Reviews

Transition from pediatric to adult follow-up care in childhood cancer survivors—a systematic review

Review

Survivorship care for cancer patients in primary versus secondary care: a systematic review

OriginalPaper

How patients experience endocrine therapy for breast cancer: an online survey of side effects, adherence, and medical team support
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits